Money Talks News on MSN
Azelastine Nasal Spray Emerges As Potential Covid Prevention Tool
Clinical trial shows over-the-counter azelastine spray may block Covid virus from entering nasal passages Man empties piggy bank after 10 years—not ready for how much he’s saved What taking melatonin ...
Called Neffy, it offers a needle-free alternative to the EpiPen used by those at risk of potentially fatal anaphylaxis to inject themselves with adrenaline.
Q. On my last few trips, I developed severe nasal allergies and runny nose while on the plane. It was uncomfortable and embarrassing. Other travelers may have thought I had a bad cold or something ...
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy ® (epinephrine ...
Children getting sick too often can be worrisome for parents. Immunity plays a vital part in maintaining a sound body and well-being. Ayurveda expert shares tips on how to strengthen the immune system ...
Thirty EMS agencies across North Carolina are approved to administer the addiction medication buprenorphine in the field; ...
ENA Respiratory has raised $34 million in a funding round to support the development of its virus-agnostic nasal spray, ...
The NHS has issued an alert to parents to take urgent action before the new school term starts by completing their child’s flu vaccine consent form. In a reminder shared on X, the health service ...
where I’m left having to entirely re-powder my nose so my face looks normal. So on the transfer-resistance front, L’Oréal does a solid job. The bottle is shaped like a hairspray bottle and the spray ...
The NHS has urged parents to do one thing before school starts again. In a post on X, it asks people to take a minute to complete their child’s flu vaccine consent form, stressing its importance. The ...
The NHS has urged parents to do one thing before school starts again. In a post on X, it asks people to take a minute to complete their child’s flu vaccine consent form, stressing its importance. The ...
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results